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ABSTRACT 
It has long been known that isolated apical domains of GroEL (known as 
“minichaperone”) have the ability to bind and assist the folding of a wide variety of 
client proteins without GroES and ATP, but only little attention has been paid so far 
to the mechanism by which these much simpler chaperones act.  Here, in order to 
probe into the mechanism of minichaperone consisting of residues 191-345 of the 
GroEL apical domain action in detail, we have examined the fate of a large, 
multidomain and highly aggregation prone maltodextrin glucosidase (MalZ) during 
minichaperone-mediated folding reactions. The key objective was to identify whether 
this MalZ is free in solution, or whether it represents protein that is still bound to, or 
cycling on and off, the minichaperone. When interference molecule like ‘GroES’ (trap 
all the hydrophobic binding sites present on the minichaperone molecule) was 
introduced during refolding process, we found that production of the native state of 
MalZ was strongly inhibited. We also observed the same findings with a trap mutant 
form of GroEL, which can stably capture MalZ that is released from minichaperone in 
a predominantly non-native conformation during refolding process in solution, but 
does not release it. Tryptophan and ANS fluorescence measurements indicated that 
refolded MalZ has the same structure as the native MalZ, but that its structure when 
bound to minichaperone is different. Surface plasmon resonance measurements 
provide an estimate for the equilibrium dissociation constant KD for the MalZ-
minichaperone complex of 0.21 ± 0.04 µM, which are significantly higher than for 
most GroEL clients. This showed that minichaperone interacts loosely with MalZ to 
allow the protein to change its conformation and fold while bound during the refolding 
process. These observations suggest that the minichaperone works by carrying out 
repeated cycles of binding aggregation-prone protein MalZ in a relatively compact 
conformation and in a partially folded but active state, and releasing them to attempt 
to fold in solution. 
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1. Introduction 
When folding, small single domain proteins generally fold rapidly into their final 
conformations via a reversible two-state mechanism (1-6), although studies at the 
level of single molecules are starting to reveal multiple pathways even in these 
apparently simple cases (7). The situation with larger multi-domain proteins is more 
complex, and details of the pathways by which they fold are still under intensive 
study using a wide range of methods (8, 9). Folding of these proteins can be 
adversely affected by their propensity to misfold, due to incorrect interactions 
between hydrophobic side chains of their domains during protein folding causing the 
formation of misfolded kinetically trapped structures or non-functional aggregates 
(10-12). This problem is even more acute in vivo, due to excluded volume effects 
that can increase the likelihood of incorrect associations occurring between nascent 
or partially folded proteins (13). Cells circumvent this problem in part by the 
expression of molecular chaperones, which act by binding to nascent polypeptides or 
by providing protected environments where proteins can fold without interacting with 
other aggregation-prone intermediates (14-17)  
The chaperonin GroEL is a complex molecular machine, consisting of 14 identical 
57-kDa subunits arranged in two identical heptameric hollow cylindrical rings (18). It 
generally requires the action of the co-chaperonin GroES, and is probably the most 
extensively studied chaperone system. GroEL assists protein folding by a cycle of 
binding and release of its clients during which they are sequestered in the cavity in 
the centre of one of the heptameric rings, which is capped transiently by the 
heptameric GroES complex during the folding cycle. The cycle is mediated by the 
binding of the client protein and by the binding and hydrolysis of ATP, and during the 
course of the cycle the complex undergoes very significant structural 
rearrangements which are critical for its action (reviewed in 19-22). Each GroEL 
protomer has three domains: an equatorial domain which provides contacts for 
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transmission of allosteric information between the two rings and also is the site for 
ATP binding, an apical domain which binds client proteins and the cochaperonin 
GroES, and an intermediate domain which acts as a hinge allowing the rigid body 
movements of the reaction cycle. An intact GroEL complex is required for the full 
activity of the protein in vivo (23, 24). Despite intense study, several aspects of its 
function remain controversial, including whether it acts passively in provision of a 
protected folding space or actively in assisting the folding process, by disruption of 
misfolded intermediates (25-29).   
Although full activity of GroEL requires the complete double ring structure, reduced 
forms can also show some activity. For example, a decrease in the tightness of the 
interaction between GroES and GroEL enables single ring forms of GroEL to support 
E. coli growth at normal temperatures and to mediate protein refolding in vitro (30-
33). Monomeric fragments of the apical domain alone, referred to as 
“minichaperones”, show polypeptide binding and protein refolding activity even 
though they lack the allosteric properties and central cavity of wild type GroEL (34). 
Minichaperones have a conformation very similar to the corresponding region in the 
intact full-length protein and bind peptides in regions corresponding to the same 
position in intact multimeric GroEL (35, 36). Minichaperones can chaperone the 
refolding in vitro of human interferon gamma, cyclophilin A and rhodanese and can 
also unfold barnase by transiently binding to folding intermediates with exposed 
hydrophobic residues (34, 37). Minichaperones cannot support viable growth on their 
own in the absence of intact GroEL, but can partially suppress the temperature 
sensitivity of some groEL mutants, showing they do have some activity in vivo (38).  
Molecular dynamics simulations have led to the proposal of two hypotheses to 
explain the mechanism of minichaperones. One proposes that the process of 
repeatedly binding and release polypeptides and that this is effective in assisting 
protein folding; this is referred to as the transient binding and release, or TBR, 
mechanism. The TBR model suggests that chaperones transiently and repeatedly 
bind proteins which are kinetically trapped in a partially folded state, disrupt their 
structure, and release them in a different state. These rounds of binding and 
releasing allow client proteins to find pathways either into the native state (which is 
no longer recognized by the chaperone), or into an unfolded state (which can 
undergo further processing by the chaperone) (39). The other is that folding by a 
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cageless chaperone-like minichaperone can only be accomplished if the protein 
binds loosely enough to the chaperone that it can change its configuration and 
fold while bound to the chaperone (40). To date, these two hypotheses have not 
been assessed experimentally.   
Here, we report the results of a study on the interactions between Escherichia coli 
maltodextrin glucosidase (MalZ) and the minichaperone GroEL (191-345) that 
addresses this issue. MalZ is a 69 kDa monomeric enzyme that catalyses the 
degradation of maltodextrin to maltose by eliminating one glucose residue from the 
reducing end at each time (41); the biochemical assay for this is simple which allows 
easy monitoring of MalZ refolding from the denatured state. Its structure is known 
(42), and as it has 22 tryptophan residues, spectroscopic studies can be done at low 
concentrations. MalZ folding in vivo is significantly enhanced by co-expression of 
GroEL and GroES, and it has been shown to fold through a trans-only mechanism 
on GroEL, as it is too large to fit in the GroEL cavity under GroES (43).  We show 
here using a range of methods that GroEL (191-345) can enhance the 
thermostability of MalZ by forming a binary complex with it, and enhances its 
refolding when presence in significant molar excess. 
 
2. Materials and Methods 
2.1. Reagents and materials 
Luria broth (LB), Luria agar (LA) and antibiotics were obtained from HiMedia 
(Mumbai, India). Standard molecular weight markers and isopropyl-d-thiogalactoside 
(IPTG) were obtained from Bangalore Genei (Bangalore, India). p-Nitrophenyl-d-
maltoside (pNPM) was obtained from Merck Biosciences (Darmstadt, Germany). Gel 
extraction and plasmid purification kits were purchased from QIAGEN (Valencia, CA, 
USA). DNA ligase and other restriction enzymes were obtained from New England 
Biolabs (Ipswich, MA, USA). All other reagents were from Sigma-Aldrich (St. Louis, 
MO, USA) unless noted. Double distilled or Milli-Q (Merck Millipore) water was used 
throughout. 
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2.2. Strains and plasmids 
DH5α, BL21, and BL21-DE3 Escherichia coli strains were used respectively for 
cloning, expression, and purification of MalZ and minichaperone. The plasmid 
pCS19MalZ contains the malZ gene fused to a hexahistidine tag, and was a 
generous gift from W. Boos (University of Konstanz, Germany) (43). The plasmid 
expressing minichaperone (pET15b-miniCh) was a generous gift from Prof. Hideki 
Taguchi (Tokyo Institiute of Technology, Yokohama, Japan). The plasmid pET23A 
expressing BirA biotin ligase (pET23a-BirA) was a generous gift from Dr. Mahboob 
Salim (University of Birmingham, U.K.).  
 
2.3. Expression and purification of minichaperone and MalZ 
Escherichia coli BL21 (DE3) cells were transformed with pET15b-miniCh and 
pCS19MalZ for overexpression of minichaperone and MalZ, respectively. A single 
colony was inoculated in 5ml LB and incubated at 37°C in a shaking incubator at 220 
RPM. When the OD600 reached 0.8, the culture was transferred into 1 litre LB 
medium and grown under similar conditions. Cultures were induced with 0.1mM 
IPTG when OD600 of 0.6 was reached; these were then further grown for 12h. The 
culture was harvested by centrifugation and washing with 20mM NaPO4, 500mM 
NaCl (buffer A), followed by resuspension in 30 ml buffer A. Cells were lysed by 
sonication, and centrifuged at 25,000 g for 60 min in a Sorvall RC6 plus centrifuge to 
yield a soluble extract. The supernatant was collected and passed through a 0.45 μm 
filter before chromatography using an AKTA FPLC system (GE Healthcare and Life 
Sciences). Both MalZ and minichaperone were purified by passing the supernatant 
through a Ni-NTA chelating column, equilibrated in buffer A containing 1 mM DTT. 
The proteins were eluted using a linear gradient of 0−500 mM imidazole. 
Minichaperone and MalZ eluted at 300 mM and 250 mM imidazole respectively. 
Fractions containing proteins were identified by SDS-PAGE, and those having 
greater than 99% purity were pooled.  
The concentration of MalZ and minichaperone were determined 
spectrophotometrically at 280nm with extinction coefficients, estimated from the 
amino acid sequences using the ProtParam tool of ExPASy 
(http://web.expasy.org/protparam/), of 152665 M−1 cm−1 and 8480 M−1 cm−1 
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respectively.  
 
2.4. MalZ assay 
The enzymatic activity of MalZ was determined as described (41). Briefly, MalZ 
activity was measured by the rate of hydrolysis of p-nitrophenyl acetate by 
monitoring the increase in the absorbance at 405 nm as a function of time.  Activity 
assays were carried out at 25°C. 
 
2.5. Minichaperone-assisted refolding of GdnHCl-denatured MalZ 
All denaturation and renaturation experiments were done in 20 mM NaPO4, pH 7.4, 
100 mM NaCl (RF buffer) at room temperature. MalZ is fully denatured in 2 M 
GdnHCl (44). MalZ (30µm) was denatured for 2h in the presence of 2 M GdnHCl. 
Renaturation experiments were initiated by diluting the sample 1: 100 in the absence 
and presence of various concentrations of minichaperone. Renaturation was 
expressed as a percentage of the activity of the same mass of native enzyme 
incubated under the same conditions. For spontaneous refolding, the same refolding 
buffer was used. To control for possible macromolecular crowding effects, both 
lysozyme and BSA were used in separate control experiments at the same 
concentration as minichaperone (45). The effect of GroES was assayed by diluting 
chemically denatured MalZ into refolding buffer in the presence of minichaperone. 
The MalZ was allowed to refold for different time duration (20-300 min) followed by 
addition of GroES to the refolding mixture. GroES and minichaperone concentrations 
were calculated with respect to monomeric molecular weight. The effect of adding a 
GroEL trap was assayed by allowing MalZ to refold in the presence of 
minichaperone, and then removing aliquots at different time points, adding GroEL 
G337S/I349E in a 1:1 molar ratio to MalZ, and determining MalZ activity after further 
10 minutes incubation.  
2.6. Time course of thermal inactivation and reactivation of MalZ 
The time course of temperature induced inactivation of MalZ was measured by 
incubating a 0.5 µM solution of the enzyme at the desired temperature (45, 50 or 
55°C) in RF buffer in the absence or presence of minichaperone and periodically 
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removing samples and assaying them for enzymatic activity at 25°C.  For 
reactivation experiments, MalZ was thermally denatured at the desired temperature 
until it lost its activity, after which samples were cooled down to 25°C. Aliquots (50µl) 
were taken at the different times following this and MalZ activity was assayed.  
2.7. Aggregation Kinetics 
The kinetics of heat-induced aggregation of MalZ were measured by light scattering 
in a Cary Eclipse fluorescence spectrophotometer equipped with a temperature 
controller and thermo probes using a quartz cuvette of path length 1 cm.  0.5 µmM 
MalZ was heated at 50°C in RF buffer alone or in the presence of different molar 
ratios of minichaperone in RF buffer. Aggregation was monitored by light scattering 
at 500 nm with excitation and emission slits 5 and 2.5 nm, respectively. Solutions 
were constantly stirred to avoid formation of bubbles.  
2.8. Purification of tagged minichaperone for SPR 
A birA tag was added to the 3’-end of the minichaperone gene to so that the 
minichaperone could be immobilized on a CN5 streptavidin-coated chip for the SPR 
experiments. To do this, a PsiI site was introduced into pET-miniGro using an Agilent 
Quick-change mutagenesis kit with primers 1 and 2 (SUP Table T1) which introduce 
a TTA before the stop codon in the minichaperone gene to make a PsiI site 
(TTATAA).  The resulting plasmid was called Mut pET-miniGro. The sequence 
encoding BirA was PCR amplified from pET23a (BirA) using primers 3 and 4 (SUP 
Table T1) and the ThermoScientific Phusion High Fidelity PCR kit. Primers were 
designed in such a way that PCR products share 15 bp of homology with the ends of 
linearized Mut pET-miniGro following digestion at the PsiI site, with the remaining 
primer sequence complementary to the BirA tag.  PCR fragments were purified using 
the Qiaquick PCR purification kit (Qiagen, UK) and the BirA tag was then integrated 
into the vector by incubating PCR-amplified birA with PsiI-cut Mut pET-miniGro with 
the In-fusion HD cloning kit. Plasmids containing fragments in the correct orientation 
were identified by DNA sequencing, and the resultant construct was named 
BirA/pET-miniGro (Fig. S2).  The presence of the BirA tag in the minichaperone 
protein was confirmed by SDS-PAGE followed by Western blotting.   
2.9. Surface Plasmon Resonance 
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A BIAcore 3000 (Sweden) surface plasmon resonance-based biosensor was used to 
measure affinity constants for the interactions between proteins. CM5 research 
grade sensor chips and P20 surfactant were from Biacore. N-Hydroxysuccinimide, 
N-ethyl-N9- (3-diethylaminopropyl) carbodiimide, and ethanolamine coupling 
reagents (Biacore) were used to immobilize 5,000 RU of the streptavidin to the 
sensor surface using a standard amine-coupling procedure.  Minichaperone protein 
containing the BirA tag (100µM) was biotinylated using succinimidyl-6-(biotinamido) 
hexonoate (NHS-LC biotin, 500µM) according to the manufacturer’s instructions.  
Biotinylated minichaperone protein was coupled to the chips to ~800-1000 response 
units. The flow cell temperature was 25°C. The running buffer was RF buffer plus 
0.005% P20 surfactant (Biacore). MalZ was denatured in 2M GdnHCl for 60 min 
confirmed through the loss of activity and loss of intrinsic fluorescence of MalZ. 
Chemically denatured MalZ protein was injected over the minichaperone coupled 
chips and streptavidin control chips with a flow rate of 10µl/min.  Binding surfaces 
were regenerated by washing with 0.5 M EDTA.  
To determine the dissociation constant (KD), the concentration of denatured MalZ 
injected onto the sensor chip was varied from 0.05 to 0.5µM. In all sensograms 
shown, the signals obtained from streptavidin control chips were subtracted from the 
signals obtained from the chips with coupled minichaperone. The KD value was 
determined from the plot of the equilibrium binding responses as a function of the 
concentrations of MalZ, using steady-state affinity program of BIA evaluation 
Software (Biacore, Sweden).  
 
2.10. Thermofluor assay 
Thermofluor experiments were performed on Stratagene MxPro QPCR system. 
Solutions of MalZ and minichaperone separately were made by mixing with 1X sypro 
orange dye and were loaded to the wells of a 96-well thin-wall PCR plate (Bio-Rad). 
The plates were sealed with Optical-Quality Sealing Tape (Bio-Rad) and heated from 
20 to 90 °C in increments of 1°C/min. The changes of fluorescence in the wells of the 
plate were detected with a charge-coupled device (CCD) camera. The excitation and 
emission wavelengths were 490 and 575 nm respectively. The concentration of MalZ 
and minichaperone were used 2µM and 8µM respectively. 
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2.11. Intrinsic and extrinsic fluorescence measurements 
Fluorescence spectra were recorded in a Cary Eclipse fluorescence 
spectrophotometer (U.S.A.) equipped with temperature controller and thermo 
probes. The excitation wavelength was 295nm. Excitation and emission slits were 
set at 5 nm. Fluorescence of ANS (8-anilino-1-naphthalene sulfonic acid) was used 
to probe the accessibility of hydrophobic surfaces on the protein. Fluorescence 
emission signals of ANS in the presence and absence of 0.5µM MalZ were collected 
in the range between 400 and 600 nm with excitation wavelength 375nm.  
2.12. MALDI-TOF mass spectrometry 
The molecular mass of minichaperone was confirmed by MALDI-TOF mass 
spectrometry (ABI Sciex 5800 TOF). Super DHB (2, 5-dihydroxybenzoic acid) matrix 
was used. Minichaperone of concentration 20µM was put to the two spot sites on a 
384-well stainless steel target plate and the samples were air-dried for 10 min. The 
matrix–organic solvent mixture (1 µL) was then added to the spot sites and air-dried 
at room temperature. The minichaperone sample was spotted in duplicate for 
reproducibility. Once the samples were completely dry, they were introduced into the 
mass spectrometer and then the spectrum was recorded.  
 
2.13. Size exclusion chromatography  
Native minichaperone (100 μM) and native MalZ (20 μM) were passed through a 
prepacked size exclusion column (Superdex-200, 10/300) pre-equilibrated with RF 
buffer connected to an AKTA FPLC system. A flow rate of 0.5 ml/min was 
maintained throughout. The MalZ/minichaperone complex was obtained by 
incubating MalZ and minichaperone (in a molar ratio of 1:5) at 50°C for 60 minutes, 
until complete loss of the MalZ activity.  The mixture was then cooled to 25°C and 
centrifuged at 14,000 rpm for 10 minutes to remove any aggregate. The supernatant 
was collected and applied to the column. Samples were injected into the column 
using a 50 μl loop. Three fractions from each of the two peaks were collected and 
run on a 12% SDS gel followed by Coomassie blue staining. The data was analysed 
using inbuilt Unicorn software (GE Health care, USA) and the area under the peak 
corresponding to MalZ and minichaperone was calculated in accordance with 
manufacturer’s instructions. 
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 3. Results  
3.1. Molecular mass determination 
The oligomerization state of minichaperone was determined by MALDI-TOF. Three 
peaks were seen (Fig. S1), suggesting that the protein exists in solution in mixed 
oligomeric states including monomers, dimers and trimers (molecular weight 18.834 
kDa, 37.556 kDa and 57.313 kDa, respectively). In the experiments below, the 
molecular mass of minichaperone was always calculated as a monomer.  
 
3.2. Minichaperone can reactivate chemically-inactivated MalZ 
 To determine the ability of minichaperone to reactivate chemically denatured MalZ, 
MalZ was unfolded in 2 M GdnHCl and then diluted 100-fold into refolding buffer in 
the presence or absence of different concentrations of minichaperone. Aliquots from 
each refolding mixture were withdrawn after 20 minutes and their MalZ activity was 
measured. As shown in Fig. 1A, the spontaneous refolding of MalZ in the absence of 
any chaperone was ~5%.  The percentage of recovery of MalZ activity ranged from 
7% (at 5-fold molar excess of minichaperone) to 45% (at 100-fold molar excess of 
minichaperone). In Fig. 1B, the model is representing the spontaneous and 
minichaperone assisted folding of MalZ. Increasing the concentration of 
minichaperone beyond 30 µM (100-fold molar excess) had no further effect on 
refolding yield.  Renaturation of MalZ was not affected by a 30-fold molar excess of 
either lysozyme or BSA, showing the renaturation is not simply caused by the 
presence of an excess of another protein with hydrophobic surfaces.  
Analysis of the time course of MalZ reactivation in the presence of 100 fold molar 
excess of minichaperone showed an initially rapid increase in MalZ activity, which 
decreased to effectively zero at twenty minutes, after which no further change took 
place up to 120 minutes (Fig. 2). Thereafter, a gradual decrease in activity was 
observed until it reached ~35% final residual activity after 180 min. This pattern of 
initial increase and subsequent decrease in activity is consistent with multiple rounds 
of binding and release with MalZ being folded into a form that is active but not fully 
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folded, and which can undergo aggregation during prolonged incubation with 
minichaperone.  
To measure the KD between minichaperone and denatured MalZ, we used surface 
plasmon resonance (SPR) with a sensor chip coated with immobilized 
minichaperone. When 2 M GdnHCl–denatured MalZ was injected onto this sensor 
chip, an increase in response units (RU) was detected (Fig. 3). No increase of RU 
was detected when native state MalZ was injected, showing that minichaperone 
does not bind to native MalZ but binds to one or more of its folding intermediates 
(Fig. 3A).  The values of RU as a function of the concentration of denatured MalZ are 
shown in Fig. 3B. These data were fitted to a hyperbolic curve according to a single 
binding affinity model using in-built nedit software.  The value of the dissociation 
constant, KD, was estimated to be 0.21 ± 0.04 µM.  Association and dissociation of 
denatured MalZ were too fast to accurately determine the kinetic constants kon and 
koff.  
 
3.3. Using GroES and a GroEL-trap as a probe suggests multiple rounds of 
binding and release of MalZ 
After 20 minutes of refolding in the presence of minichaperone, MalZ regains ca. 
45% of its activity, and, as discussed above, SPR showed that the binding of MalZ to 
minichaperone is relatively weak. We wished to know whether this MalZ is free in 
solution, or whether it represents protein that is still bound to, or cycling on and off, 
the minichaperone. As the minichaperone is part of the GroEL apical domain and 
contains the hydrophobic sites to which GroES binds (46), we investigated the use of 
GroES as a competitor to probe the interaction between MalZ and minichaperone.  
Different amounts of GroES were added to the folding reaction after 20 minutes, at 
which point the MalZ has regained its maximal level of activity. The results (Fig. 4A) 
showed that addition of GroES caused a concentration-dependent drop in MalZ 
activity, reaching a maximum at a two-fold molar excess of GroES, after which no 
further effect was seen. At this concentration of GroES, only 15% of MalZ activity 
could be recovered. We interpret this as showing that approximately two thirds of the 
measured activity of MalZ at 20 minutes is due to protein that is still interacting with 
the minichaperone and is still aggregation-prone. We propose that when GroES is 
added, some of this bound MalZ protein is displaced into the solution, where it either 
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misfolds or aggregates. If this hypothesis is correct, then we can predict that the 
addition of a molar excess GroES to the refolding mix at the start of the reaction will 
remove the effect of the minichaperone, since all the sites needed to bind the MalZ 
client protein will be occupied by higher affinity GroES. As a result, only 5% refolding 
activity would be achieved, equivalent to spontaneous refolding. We confirmed that 
this was indeed the case (Fig. 4b). This figure also shows that GroES alone does not 
interfere with the spontaneous refolding of MalZ in the absence of minichaperone. 
This hypothesis was further tested using spectroscopic methods, described below. 
 
Our observation (Fig. 2) that MalZ activity in the refolding reaction gradually declined 
after 20 minutes to a final stable level of 35% is consistent with a TBR model where 
bound MalZ continues to cycle on and off the minichaperone and as it does so some 
folds into the stable native state and some is lost to aggregation.  By this model, the 
minichaperone is exerting its effect predominantly by providing hydrophobic surfaces 
to which unstable intermediates can transiently bind, thus reducing the concentration 
of those intermediates in the folding solution.  If this model is correct, we would 
predict that over time the effect of GroES on the refolding reaction would decrease, 
since less MalZ would be bound by the minichaperone and hence be able to be 
competed off by GroES binding, and more would be fully folded in solution. We 
tested this by adding GroES to a minichaperone/MalZ refolding reaction at different 
times after initiating the reaction and confirmed that the effect of GroES did indeed 
decrease, until at 180 minutes it had no effect on yield at all (Fig. 5). 
 
Although this result is consistent with the TBR model, it does not rule out the 
possibility that folding takes place entirely on the surface of the minichaperone, and 
that when used as a probe GroES displaces the MalZ into the solution due to its 
higher affinity for the sites to which MalZ binds. To distinguish these two possibilities, 
we used a trap variant of GroEL (GroEL G337S/I349E (47)), which can stably 
capture non-native MalZ in solution, but does not release it. We first showed that the 
presence of the GroEL trap alone has no impact on spontaneous refolding of MalZ 
(Fig. 6A).  We then allowed MalZ to fold in the presence of minichaperone, removed 
aliquots at different time points, added the GroEL-trap in a 1:1 molar ratio with MalZ, 
and determined MalZ activity after further 10 minutes incubation.  The results (Fig. 
6B) showed that for the first 100 minutes of the reaction, the addition of GroEL-trap 
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reduced MalZ activity to ~5%, equivalent to spontaneous refolding. When GroEL-trap 
was added later, the reduction was reduced, and after 180 minutes, no effect on the 
yield was seen. This is more consistent with the TBR model, with the trap binding to 
and preventing further refolding of MalZ that is cycling on and off the minichaperone, 
and with the appearance of an intermediate (or fully folded) form of the protein that 
does not bind to GroEL trap at approximately 100 minutes.   
 
3.4. Fluorescence analysis of intermediates in minichaperone-assisted 
refolding 
To get a more detailed insight into the conformations of MalZ intermediates formed 
during minichaperone-assisted refolding in both the absence and presence of 
GroES, MalZ was further characterized by intrinsic and extrinsic fluorescence 
spectroscopy.  
Fluorescence can be used to specifically examine MalZ because minichaperone 
lacks tryptophan residues, whereas MalZ from E. coli contains 22 tryptophan 
residues (41). Fig. 7A shows the fluorescence spectra of different conformations of 
MalZ. Native MalZ exhibited an emission maximum at 341 nm (curve a), whereas in 
2 M GdnHCl, in which MalZ fully unfolds (44), the emission maximum was shifted to 
356 nm (curve f). This corresponds to the fluorescence maximum of tryptophan in 
aqueous solution, the red shift of fluorescence λmax reflecting transfer of Trp 
residues to a more polar environment. However, the fluorescence spectrum of MalZ 
refolded for 20 minutes from a GdnHCl-denatured state in the presence of 
minichaperone exhibited λmax at 346 nm (curve b). The blue shift of λmax from the 
MalZ unfolded state suggests that at least some of the tryptophan residues have 
returned to a native state environment. These results provide further supporting 
evidence for the hypothesis that MalZ bound to minichaperone is neither native-like 
nor completely unfolded but more in a partially folded intermediate. Curve e shows 
the spectrum when GroES was added after 20 minutes to the sample refolded in the 
presence of minichaperone. This reduced the fluorescence intensity of MalZ by 53% 
(compared to fluorescent intensity of MalZ refolded in the presence of 
minichaperone; curve b), with a slight blue shift (λmax=344 nm). This is consistent 
with the model proposed above that GroES displaces bound MalZ intermediate from 
minichaperone and prevents further interactions; the loss in fluorescence intensity 
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and the blue shifted spectrum is consistent with the release of more compact MalZ 
along with the aggregation of loosely folded intermediates. We further observed that 
when the fluorescence spectrum of MalZ refolded in the presence of minichaperone 
was recorded with or without GroES after 180 min of refolding, the λmax shifted to 
342 nm (curves c and d), similar to that of native MalZ. This indicates recovery of 
substantial tertiary structure following prolonged incubation with minichaperone, 
consistent with the results above. The fluorescence intensity is somewhat reduced, 
presumably due to loss of aggregated protein during refolding. 
The compactness of MalZ at different stages of refolding under different conditions 
was further analysed by using the external fluorescent probe 1-anilino-naphthalene-
8-sulphonate (ANS), which is widely used to report the different states that occur 
during protein folding, with the results shown in Fig. 7B. In aqueous solution, ANS 
has very weak fluorescence intensity with λmax of 525. As shown in Fig. 7B (bar 1), 
the ANS fluorescence intensity of native MalZ was also very low, as expected since 
hydrophobic side chains are largely buried in native globular proteins. Both 
minichaperone (bar 2) and GroES (bar 3) show moderate fluorescence, consistent 
with the exposure of some hydrophobic residues in the native states of these 
proteins.  The ANS fluorescence of the GroES and minichaperone mixture (bar 6) 
was much less than the sum of their individual fluorescences. This suggests that 
they are interacting in a way that leads to burial of some of the hydrophobic residues, 
consistent with the proposed interaction of the GroES with the binding site on the 
minichaperone. Denatured MalZ exhibited almost the same fluorescence intensity as 
the native form, consistent with our earlier studies (44 and data not shown). 
However, denatured MalZ when refolded for 20 minutes in the presence of 
minichaperone exhibited high ANS fluorescence (bar 5). This gain in the ANS 
fluorescence intensity, along with blue shifting of the spectrum, points towards 
generation of exposed hydrophobic regions in the MalZ/minichaperone complex 
during refolding. To probe the effect of adding GroES to the MalZ-minichaperone 
mix, the ANS fluorescence of minichaperone and GroES was monitored. The ANS 
fluorescence of MalZ that has been refolded for 20 minutes in the presence of 
minichaperone followed by addition of GroES (bar 7) is higher than the fluorescence 
of GroES and minichaperone alone (bar 6). However, after 180 minutes of refolding 
in the presence of minichaperone without or with the addition of GroES, native-like 
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ANS fluorescence was observed (bars 8 and 9 respectively). This is consistent with 
the earlier data suggesting that MalZ acquires a structurally compact and native-like 
conformation after 180 minutes of refolding in the presence of minichaperone. 
 
3.5. Minichaperone reduces thermal inactivation and enhances reactivation of 
MalZ 
A further test of the role of minichaperone was undertaken by studying its impact on 
thermal inactivation of MalZ. We examined the fluorescence spectrum of MalZ after 
heating to 50°C, and found it had a λmax of 346 nm, intermediate between that of 
native and chemically denatured MalZ maximum. This is consistent with the protein 
retaining some structure at this temperature. By determining the melting temperature 
(Tm) for both proteins, we found minichaperone to be more thermally stable than 
MalZ, consistent with earlier reports (48) (Fig. S3).  We then examined the ability of 
minichaperone to protect MalZ against thermal inactivation at different temperatures.  
We measured the ability of minichaperone to protect MalZ against thermal 
aggregation at 50°C at a range of molar ratios (Fig. S4) by using light scattering to 
detect the presence of aggregates. The smaller molar excess of minichaperone 
which is required to protect MalZ against thermal denaturation relative to chemical 
denaturation may be due to the increase in hydrophobic interactions with 
temperature . The rates of thermal inactivation of MalZ activity were then determined 
in the presence and absence of minichaperone at 45°C, 50°C and 55°C. The results 
are shown in Fig. 8. A single-exponential equation was found to fit well to the data 
points (regression coefficient 0.98), showing that the inactivation follows first-order 
kinetics and is strongly temperature dependent. The first order rate constants for the 
inactivation reactions were estimated and are shown in Table 1. We concluded that 
the presence of minichaperone substantially reduced the rate of thermal inactivation 
of MalZ, particularly at 45°C. 
 
 
If MalZ was cooled from 45°C to 25°C, almost full recovery of activity of MalZ was 
seen on incubating the sample for five minutes, even in the absence of 
minichaperone. However, reactivation after incubation at 50°C and 55°C was very 
low or absent. We examined whether the presence of minichaperone had an effect 
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on these results.  As shown in Fig. S5, if MalZ enzyme that had been thermally 
inactivated in the presence of minichaperone was shifted from 50°C to 25°C a high 
recovery (about 65%) of activity of MalZ was obtained. A recovery of less than 10% 
was observed in the absence of minichaperone or in the presence of lysozyme 
(inset, Fig. S5). No MalZ reactivation was detected on shifting the samples from 
55°C to 25°C followed by prolonged incubation, even in the presence of 
minichaperone.  The protective effect of minichaperone was observed only if 
minichaperone was present during the initial high temperature incubation; addition at 
the time of temperature shift to 25°C did not result in MalZ reactivation (data not 
shown). This is consistent with formation of a minichaperone/MalZ complex during 
the thermal unfolding of MalZ at 50°C, which keeps MalZ in a reactivable form. This 
gave us the opportunity to use size exclusion chromatography to determine the 
nature of the species involved.   
 
When native minichaperone was mixed with native MalZ at 25°C in a 5:1 molar ratio 
and run on a size exclusion column both proteins eluted as separate peaks at 17 ml 
and 15 ml respectively (Fig. 9A), consistent with a lack of measurable interaction 
between the proteins in their native states. When MalZ was heated alone at 50°C 
until its activity was reduced to zero, cooled to 25°C, and centrifuged before 
application to the column, no peak was observed, consistent with the formation of 
high molecular weight insoluble aggregates under these conditions (Fig. 9C). In 
contrast, when minichaperone was heated alone for 60 min and analyzed, no 
change in retention time was observed, confirming that minichaperone does not 
become insoluble on heating (Fig. 9B). We then incubated minichaperone and MalZ  
together in a 5:1 molar ratio at 50°C for 60 min, cooled them to 25°C, centrifuged 
them at high speed and applied them to the column.  Two peaks were obtained (Fig. 
9D) at the position of MalZ and minichaperone. Different fractions corresponding to 
each peak were collected and run on a 12% SDS-PAGE to analyze the species 
present. Only MalZ was seen in the earlier peak (Lanes 1-3, Figure 9E), but 
minichaperone plus a small amount of MalZ protein was seen in the later peak 
(Lanes 4-6, Fig. 9E), indicating that some of the MalZ was bound with minichaperone 
in a complex. It thus appears that some of the thermally denatured MalZ proteins 
regained their native conformation with the help of minichaperone and were released 
from the complex, while some are still attached to the minichaperone. A higher 
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elution time of MalZ/minichaperone complex (Fig. 9D) can be attributed to the 
interaction of a hydrophobic complex of MalZ/minichaperone with that of the size 
exclusion column matrix (49). 
 
4. Discussion 
There is debate about whether minichaperones mediate folding through a single 
round of association followed by folding on the surface of the minichaperone and 
eventual release of native forms, or through cycles of binding and release in which 
only a fraction of released molecules reaches the native form in any cycle (39, 40). 
While studying the molecular organization of minichaperone, we found that 
minichaperone exists in solution in a polydispersed state, and we detected mixed 
oligomeric species (monomer, dimer and trimer; Fig. S1). Our results show that 
when allowed to refold in the presence of minichaperone, MalZ denatured in 2 M 
GdnHCl exhibits a functional intermediate state, part of which eventually undergoes 
irreversible inactivation, but much of which can be folded to an active form if an 
excess of minichaperone is present. The residual activity was significantly higher 
(35%) than that of spontaneous refolding (5%) or folding in the presence of excess 
lysozyme or BSA (both proteins with significant surface hydrophobicity), affirming the 
chaperoning effect of minichaperone. Studies using GroES as a competitor at 
different time intervals during MalZ refolding suggest that during the early stage of 
refolding, some fraction of denatured MalZ is partially folded into an enzymatically 
active conformation (i.e., a functional intermediate), but that this intermediate is still 
aggregation prone and may be still cycling on and off the minichaperone. Such 
functional intermediates have been reported in the refolding pathways of malate 
synthase G (50). The GroEL-trap experiments confirm that the intermediate spends 
at least some time in free solution. Our experimental data support the Transient 
Binding and Release (TBR) model of chaperone assistance by minichaperone with a 
MalZ protein, as proposed in simulations (39) and both the ANS and tryptophan 
fluorescent data are fully consistent with the TBR model. It shows that the apical 
domain of GroEL alone weakly, transiently and repeatedly binds and releases the 
client protein, supporting its refolding in an ATP-independent process. Other in vitro 
studies with purified client proteins like rhodanese, RUBISCO, and malate 
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dehydrogenase also suggest that cycles of binding and release are linked to the 
chaperonin-assisted production of the native state (51-53). The refolding reaction to 
one or a collection of functional intermediates that are enzymatically active is 
relatively rapid, taking place in the first twenty minutes of the experiments, and is 
abolished by the presence of either GroES or GroEL-trap. This shows that the 
binding to the minichaperone reduces non-productive aggregation (possibly by 
lowering the concentration of the MalZ in free solution) but also that cycling of MalZ 
on and off the minichaperone must be occurring in this time. Hence, due to the cycle 
of binding and release, the protein concentration is reduced in the bulk solvent and 
as a result, the probability of aggregation formation decreases. Because of this, 
there is an enhancement in the yield of protein in the native state. Similar 
observations have been reported with regard to GroEL/ES- assisted folding 
pathways (54). The fluorescence studies of the intermediate are consistent with this 
interpretation. Similar intermediates states have been proposed in the case of 
chaperonin-assisted folding of DHFR and rhodanese (55). MalZ reached a state that 
is either fully folded, or at least no longer aggregation prone or able to be bound by 
GroEL-trap, after 180 minutes of refolding in the presence of the minichaperone.  
The precise mechanism of the minichaperone is still not known. It could be inducing 
the MalZ to form an active intermediate that structurally favours non-local 
interactions with minimum energetic barriers, thus helping in attainment of native 
structure, and this could still take place while the protein is bound.  However, its role 
may be more of a kinetic partitioning one, where unfavourable events that could lead 
to aggregation (which will require collision of partially folded intermediates and hence 
will be concentration dependent) are reduced purely by most of the protein being 
bound to the minichaperone at any given time, even though it is also cycling on and 
off.  Binding of the intermediate is clearly demonstration by the SPR experiments, as 
well as by the SEC of a minichaperone-MalZ complex that was seen to be present 
when minichaperone assisted in the refolding of thermally denatured MalZ.  We note 
that the binding of MalZ to the minichaperone is weaker than that of other proteins to 
GroEL. For example, the binding constant of the complex between GroEL and 
reduced form of alpha albumin (rLA) has previously been measured by SPR, and in 
this case the KD was estimated to be 1.06 nm (56). The binding constant of 
complexes between GroEL and clients like non-native lactate dehydrogenase, and a 
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peptide derived from β-lactamase which were measured by SPR and for which KD 
values were estimated to be 9 nM and 10-100 nM respectively (57-58).  This is 
consistent with the model which states that weak binding may be necessary to allow 
cageless chaperones to release their protein clients without the aid of ATP (40). 
Like minichaperone, monomeric GroEL (one subunit of GroEL that is unable to form 
a central cavity) also possesses chaperone like activity and helps in prevention of 
aggregation and folding of chemically denatured client protein in the absence of 
GroES and ATP (59). The present study showed that a yield of 45% requires 100–
fold molar excess of minichaperone, whereas up to 50% MalZ reactivation has been 
observed in the presence of only 1-fold molar excess of the complete GroEL system 
(43) and 25% MalZ activity regained in the presence of 14 fold molar excess of 
monomeric GroEL (59). This is consistent with the reported need for a large excess 
of cageless chaperone molecules to be present for them to be effective (24, 60). This 
may be necessary to reduce the likelihood that multiple proteins will bind to the same 
chaperone, which could lead to aggregation, or may simply be a reflection of the 
weak binding and the need to reduce the overall level of protein in free solution. The 
much lower stoichiometry required for minichaperone to refold thermally denatured 
MalZ is likely to be a reflection of incomplete denaturation of the heated MalZ; it may 
for example be the case that early folding intermediates produced by chemical 
denaturation are much more prone to aggregation and hence need a much high 
concentration of minichaperone to refold. We note from our thermal data that 
residual activity of MalZ decreases to zero at 45°C (Fig.8A), whereas full protein 
melting was only seen at 50°C (Fig. S3). This is likely to be because MalZ was 
heated from 20 to 90°C in increments of 1°C/min to determine the melting 
temperature, in contrast to the experiment shown in Figure 8A, where MalZ was 
heated at 45°C for a long time (Fig.8A), suggesting a slow loss of full structure 
occurs even at 45°C. The need for minichaperone to be present for recovery from 
thermal denaturation of MalZ, when misfolding and/or aggregation are most likely to 
occur, has also been observed with firefly luciferase and citrate synthase (61, 62).  
The failure of minichaperone to significantly protect MalZ heated to 55°C is 
reminiscent of the situation with small HSPs, which fail to reactivate citrate synthase 
denatured at higher temperatures (63). 
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Our present data provide a detailed insight into the action of minichaperone on one 
specific client, including some insight into the conformations that this client adopts 
during refolding, and in general support the TBR model for minichaperone assisted 
folding, though the possibility that some folding takes place on the chaperone 
surface itself certainly cannot be ruled out. However, we still do not understand 
completely the precise way in which minichaperone facilitate the folding of proteins. 
More work needs to be done to study the thermodynamic and kinetics of the folding 
of MalZ in the presence of minichaperone to gain further insights into the functioning 
of minichaperone as a chaperone. With the current sets of experiments it was not 
possible to determine how many cycles are needed before a non-aggregation prone 
intermediate is produced, although the GroEL-trap experiments showed that this was 
a slow process.  Additional experiments using FRET or stopped-flow kinetic analysis 
are needed to investigate this. Taking into consideration the present studies, and 
further careful investigation on the changing conformational properties of a large 
protein along the minichaperone assisted folding pathway in the near future, this type 
of study can open the window to explore interactions between folding intermediates 
and minichaperone for elucidating the chaperone-assisted folding pathways of 
multidomain proteins.  
It is tempting to speculate that molecular chaperones may have evolved from 
proteins analogous to the minichaperone described here, using ATP-independent 
cycling on and off the chaperone to protect the client from misfolding, and only later 
acquired the ATP-dependence seen in full length chaperones such as GroEL and 
DnaK.  
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Table 1. First-order rate constants for thermal inactivation of MalZ in absence and 
presence of minichaperone. MalZ was at 0.5µm and minichaperone was at 2.5µm.  
 
Temp 
(°C) 
 
Rate constant (min-1) 
 Without 
minichaperone 
With  
minichaperone 
45 0.038 ± 0.004 0.004 ± 0.0003 
50 0.25 ± 0.03 0.10 ± 0.015 
55 0.56 ± 0.04 0.12 ± 0.01 
 
 
SUP Table T1. Primers used for birA gene amplification and vector modification 
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Primers                        Sequences (5’-3’) 
 
1.       GCAATCCAGGGCCGTTTATAAGGATCCGGCTGC 
2.       GCAGCCGGATCCTTATAAACGGCCCTGGATTGC 
3.       GCAATCCAGGGCCGTTTAGGTGGTGGTCTGAACGAT              
4.       GCAGCCGGATCCTTACCATTCGATTTTCTGAGC 
 
The introduced TTA IS shown in bold letters. In primer 3 and 4, the coding sequence 
for the birA gene is underlined 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE LEGENDS 
 
Fig. 1. In vitro refolding of GdnHCl denatured MalZ in the absence or presence of 
minichaperone. (A) MalZ activity after 20 min of refolding is shown relative to the 
same amount of native MalZ (N-MalZ) (bar 1). Refolding was initiated by diluting 2 M 
GdnHCl denatured MalZ into the RF buffer under the following conditions: SRf MalZ, 
RF buffer alone; MalZ+ lyso(1:30), buffer containing 30 molar excess of lysozyme; 
MalZ+BSA (1:30), buffer containing 30 molar excess of BSA; MalZ + mini (1:X), 
refolding in presence of X-fold molar excess of minichaperone. Numbers above bars 
show percentage of recovered MalZ activity. Final concentration of MalZ was 0.3 µM.  
Error bars represent standard deviations calculated from three separate 
experiments. (B) Model represents the refolding of chemically denatured MalZ in the 
presence or absence of minichaperone. Denatured MalZ was allowed to refold in the 
presence of minichaperone for the initial 20 minutes, a transient interaction between 
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MalZ and minichaperone occurred. Spontaneously refolded MalZ undergoes 
extensive aggregation with only 5% recovery of the activity 
Fig. 2. Time course of reactivation of MalZ with minichaperone. MalZ unfolded in 2 M 
GdnHCl was diluted into a refolding buffer containing a molar excess of 
minichaperone. At the indicated time intervals, aliquots from the refolding mixture 
were withdrawn and MalZ activity was measured. The final concentration of MalZ 
and minichaperone used were 0.3 µM and 30 µM respectively. Error bars represent 
SD from three separate experiments 
Fig. 3. (A). Sensorgrams showing the binding of folding intermediate (solid line) and 
native (broken line) MalZ to immobilized minichaperone. Injections were done at time 
zero for 60 s. (B) Relationship between the equilibrium binding response and 
concentration of denatured MalZ. The solid line shows the fitted curve for a single 
binding site affinity model using BIA evaluation program. 
Fig. 4. Effect of GroES on MalZ activity during refolding in the presence of 
minichaperone. (A) Effect of increasing GroES concentration on the refolding of 
GdnHCl-denatured MalZ in the presence of minichaperone. MalZ was refolded in the 
presence of minichaperone as described. After 20 min, GroES was added at 
different molar ratios to the refolding mixtures, as indicated, and the enzyme activity 
was measured. (B) GroES-mediated refolding of MalZ in the absence or presence of 
minichaperone.  MalZ unfolded in 2 M GdnHCl was diluted into a refolding buffer in 
the presence of minichaperone alone (bar 1), minichaperone and 2-fold molar 
excess of GroES over minichaperone (bar 2), or the same amount of GroES alone 
(bar 3). Refolding was allowed to proceed for 20 min, and the mixture was assayed 
for MalZ activity. Protein concentrations and error bars are as in Figure 2.  
Fig. 5. Time course of reactivation of MalZ with minichaperone in the absence or 
presence of GroES.  MalZ unfolded in 2 M GdnHCl was diluted into a refolding buffer 
containing minichaperone. At the indicated time intervals, aliquots from the refolding 
mixture were withdrawn and measured for enzymatic activity. GroES was added in a 
2:1 ratio to minichaperone at different times after initiating the refolding reactions. At 
the indicated time intervals, aliquots from the refolding mixture were withdrawn and 
measured for enzymatic activity. Downward arrows show the measured level of MalZ 
activity after GroES addition. Protein concentrations and error bars are as in Figure 
2.  
Fig. 6. Impact of GroEL G337S/I349E trap on refolding of MalZ in presence and 
absence of minichaperone. A) Effect of GroEL G337S/I349E on refolding of MalZ. 
MalZ unfolded in 2 M GdnHCl was diluted into a refolding buffer containing GroEL 
G337S/I349E. Aliquots from the refolding mixture were withdrawn at indicated time 
intervals and MalZ activity was determined. B) Minichaperone-mediated refolding of 
MalZ in the presence of GroEL-G337S/I349E. MalZ was unfolded and refolded as in 
panel A, with minichaperone present in the refolding buffer. GroEL G337S/I349E 
was added in a 1:1 molar ratio to MalZ at different times after initiation of refolding as 
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shown, and MalZ activity was measured 10 minutes after this. Protein concentrations 
and error bars are as in Figure 2.  
Fig. 7. Monitoring conformational changes of MalZ during refolding with 
minichaperone in the absence or presence of GroES. MalZ unfolded in 2 M GdnHCl 
was diluted into a refolding buffer containing minichaperone and was allowed to 
refold for 20 min or 180 min. GroES was then added. (A) Tryptophan fluorescence 
spectra of different conformation of MalZ. Fluorescence spectra of the MalZ under 
different conditions.  a: Native MalZ; b: + minichaperone at 20 min; c: + 
minichaperone at 180 min; d: + minichaperone with GroES added at 180 min; e: + 
minichaperone with GroES added at 20 min; f: MalZ denatured in 2M GdnHCl. (B) 
ANS fluorescence of different conformations of MalZ, minichaperone, and GroES. 1: 
Native MalZ; 2: minichaperone alone; 3: GroES alone; 4: Native MalZ + 
minichaperone after substraction of fluorescence of minichaperone alone; 5: MalZ + 
minichaperone at 20 min; 6: minichaperone and GroES mix; 7: minichaperone + 
MalZ with GroES added at 20 min; 8: minichaperone + MalZ at 180 min; 9: 
minichaperone + MalZ with GroES added at 180 min. Florescence was recorded 
after incubation with 50µM ANS for 5 min at 25oC.  Error bars represent SD 
calculated from three separate experiments. 
 
Fig. 8. Residual MalZ activity following thermal denaturation in the absence (red line) 
and presence of 2.5 µM mini-chaperone (pink line). Panel (A), incubation at 45°C. 
Panel (B), incubation at 50°C. Panel (C), incubation at 55°C. Samples were 
withdrawn at the times shown and the residual activity of MalZ was determined at 
25°C. The continuous lines are the fits to the data, generated using Graphpad Prism 
software. Error bars represent SD calculated from three separate experiments. The 
final concentration of MalZ was 0.5 µM.  
Fig. 9. Reactivation of thermally denatured MalZ in presence of minichaperone 
investigated by Size Exclusion Chromatography. The traces show (A) Native 
minichaperone (N-mini) and MalZ (N-MalZ) elution peaks; (B) minichaperone heated 
at 50°C (Tht– mini) for 60 min; (C) thermally refolded MalZ in absence of 
minichaperone heated at 50°C for 60 min; and (D) thermally refolded MalZ in 
presence of minichaperone (D). Gel filtration profiles were monitored by absorbance 
measurements at 280 nm. mAU = milli absorbance units. (E) SDS-PAGE gel 
showing the MalZ-minichaperone binary complex. Lane 1-6: fractions as shown in 
chromatogram (D). The numbers appearing on each of the two peaks represent the 
three fractions constituting the peak. Thus the intensity of MalZ bands in SDS gel 
represents the eluted protein distributed in three fractions. Lane 7: Molecular weight 
markers in kDa. 
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 Supplementary Figures 
 
Fig. S1 
 
Fig.S1. Detection of oligomeric forms of minichaperone.  MALDI-TOF MS of 
minichaperone (20µM) demonstrating oligomerization of minichaperone showing 
monomer, dimer and trimer with molecular masses of 18834.9, 37556.2 and 56313.7 
Da, respectively. 
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 Fig. S2 
 
 
 
 
 
Fig. S2.representation of Pet 15b containing BirA gene and minichaperone gene.  
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Fig. S3.  
 
 
 
 
Fig. S3. Melting curves for MalZ (black curve) and minichaperone (red curve), 
determined by thermofluor. Here, Tm was identified by plotting the first derivative of 
the fluorescence emission, -d(RFU)/dT, against temperature. Tm is given by the 
lowest part of the curve. 
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Fig. S4.  
 
 
 
Fig. S4. Prevention of thermal aggregation of MalZ by minichaperone. 0.5µM MalZ 
was incubated at 50°C in the absence or presence of increasing amounts of 
minichaperone as indicated. The molar ratio of MalZ and minichaperone is indicated 
against each aggregation trace. Aggregation kinetics was monitored by light 
scattering at 500nm and normalized to the value of MalZ aggregation in the absence 
of minichaperone. The green star trace shows that minichaperone alone does not 
aggregate at 50°C.  
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Fig. S5. 
 
 
 
Fig. S5. Reactivation of thermally inactivated MalZ. A) 0.5µm MalZ was subjected to 
thermal denaturation at three different temperatures (as shown in different bars) in 
the absence or presence of 2.5 µM minichaperone until its activity was reduced to 
zero. Samples were then cooled down to 25° C and reactivation of MalZ was 
measured. The extent of regain of activity is expressed as a percentage of the 
activity of the same amount of native MalZ. Here Dn , SRf  and Rf  represents 
denatured, spontaneously refolded and refolded MalZ respectively. B) Time course 
of reactivation of MalZ at 25°C in the absence or presence of lysozyme and 
minichaperone. In this experiment, MalZ was denatured at 50°C (indicated by arrow) 
for 60 min in the absence ( ) or presence of 2.5 µM lysozyme ( ) or 2.5µM 
minichaperone ( , Red color). After 60 min, samples were then cooled to 25°C and 
reactivation of MalZ was measured over time. 
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